Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 14, 1999Journal of Medicinal ChemistryOpen Access

Urea−PETT Compounds as a New Class of HIV-1 Reverse Transcriptase Inhibitors. 3. Synthesis and Further Structure−Activity Relationship Studies of PETT Analogues

View Full Paper
Ask AI
Bookmark
Share

Authors

MHMarita HögbergNoviga Research (Sweden)CSChrister SahlbergMedivir (Sweden)PEPer EngelhardtMedivir (Sweden)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Högberg et al. (1999) studied this question.

synapsesocial.com/papers/6a75e77ef0e270a4f3b1da95https://doi.org/10.1021/jm990095j
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1New Soluble-Formazan Assay for HIV-1 Cytopathic Effects: Application to High-Flux Screening of Synthetic and Natural Products for AIDS-Antiviral Activity1989 · 690 citations
  2. 2EPITAX: a computer-assisted graphical representation of the bicrystallography of general interfaces1991 · 233 citations
  3. 3Designed catalyst for enantioselective Diels-Alder addition from a C2-symmetric chiral bis(oxazoline)-iron(III) complex1991 · 443 citations
  4. 4L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase1995 · 484 citations
  5. 511th Conference on Retroviruses and Opportunistic Infections2004 · 424 citations